PLS Group Limited Overview
PLS Group is Australia's largest pure-play lithium producer and owns 100% of the Pilgangoora Operation in Western Australia's Pilbara region, which the company describes as the world's largest independent hard-rock lithium operation. It mines spodumene-bearing pegmatite and produces spodumene concentrate (≈5.2–5.3% Li2O) plus tantalite by-product, selling predominantly into China's lithium chemical conversion industry under offtake and spot/auction arrangements. FY26 was a record year: production of 879.5kt, revenue of A$1,934M, underlying EBITDA of A$1,137M (59% margin) and NPAT of A$526M, with A$2.29bn of cash at year-end following an inaugural US$600M bond. Beyond Pilgangoora, PLS holds the Colina lithium project in Brazil (acquired via Latin Resources), an 18% stake in a lithium hydroxide plant in South Korea with POSCO, and a mid-stream demonstration plant. Its strategy is "through-cycle": preserve low-cost capacity in downturns and expand (Ngungaju restart, P2000 to ~2Mtpa) when prices recover.
What the company does. PLS is an upstream lithium raw-materials producer. Its core economic activity is open-pit mining of lithium-caesium-tantalum (LCT) pegmatites at Pilgangoora (approx. 120km south of Port Hedland), crushing and beneficiation (including dense-media separation, flotation and TOMRA sensor-based ore sorting) to produce spodumene concentrate, and trucking concentrate to Port Hedland for export. Tantalite concentrate is a minor by-product credited against unit costs.
Company self-description (FY26 release "About PLS", paraphrased). PLS characterises itself as a leading global producer of lithium materials with a diversified portfolio and strategic partnerships across the battery materials sector; it owns 100% of Pilgangoora and the Colina Lithium Project in Brazil, and is integrated further down the value chain via its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide. It lists enduring partners including POSCO and Ganfeng (earlier releases also name Chengxin, Yahua and General Lithium).
Business model. Commodity producer with price-taker economics. Revenue is almost entirely product sales (spodumene concentrate, with tantalite by-product); there is no meaningful service, subscription or licensing revenue. Contract structures include:
Value-chain position. Stage 1 (mining/concentration) is the core. PLS has optionality in Stage 2 (mid-stream lithium phosphate/"lithium salts" via the Mid-Stream Demonstration Plant, with ARENA grant funding and offtake in place, commissioning from April 2026, first product expected September Quarter 2026) and Stage 3 (chemical conversion via an 18% interest in POSCO Pilbara Lithium Solution (P-PLS), Gwangyang, South Korea, with a call option to increase its stake; the Shareholders Deed was amended in FY26 to extend the call option).
Customer types and end-markets. Direct customers are lithium chemical converters (China, South Korea). End demand is lithium-ion batteries for electric vehicles (dominant), stationary energy storage systems (ESS; the fastest-growing segment in 2025–26), and consumer electronics, plus minor industrial uses (glass/ceramics, greases).
Independent characterisation. PLS is best understood as a high-beta, low-cost, scale producer whose earnings are a near-linear function of the SC6 spodumene price. Its competitive moat is reserve scale (214Mt Ore Reserve as at the August 2023 update, adjusted for depletion), 100% ownership (no JV leakage since the Altura acquisition), and a sub-A$600/t FOB cost base, which places it in the lower half of the hard-rock cost curve. Its strategic differentiation versus most ASX peers is balance-sheet strength: it entered the 2026 upturn net-cash, whereas many peers were geared (Jarden, Feb 2026). Diversification (Brazil, chemicals) remains early-stage and immaterial to earnings.
Strategy
Stated strategy (FY26 themes, paraphrased). Management describes a "through-cycle" strategy: position the business in the downturn to respond quickly when prices recover, then pivot "from defence to growth". FY27 priorities: maximise production and cash generation from Pilgangoora, advance Colina, progress P2000 toward FID, maintain capital discipline, and keep financial flexibility against lithium volatility. The 100% ownership model is emphasised as allowing rapid capture of growth.
FY27 guidance (June 2026 quarterly, 30 Jul 2026).
Product Portfolio
| Product / offering | Description & specification | Target customer | Year / version | Pricing model |
|---|---|---|---|---|
Spodumene concentrate (SC5.2–SC5.3) | Lithium aluminosilicate concentrate; FY26 average grade 5.3% Li2O produced; lithia recovery 76.5% FY26 (71.9% FY25) | Chinese and Korean lithium converters | Since 2018; current spec SC5.2–5.3 | Index-linked (SC6 CIF China basis, adjusted for grade); FY26 realised US$1,488/t (SC5.2) = US$1,708/t SC6-equivalent |
Tantalite concentrate | Tantalum by-product; 220,585 lb produced, 239,095 lb shipped FY26 | Tantalum processors | Since 2018 | Contract/market price; credited against unit cost |
Ngungaju-sourced concentrate | ~200ktpa from restarted plant; higher cost; supports Canmax offtake | Canmax Technologies and others | Restart Jul 2026 | Offtake with US$100M prepayment |
Mid-stream lithium product (demonstration) | Mid-stream product from the demonstration plant; ARENA grant; offtake in place | Converters / cathode supply chain | First product expected Sep Qtr 2026 | — |
Lithium hydroxide (via P-PLS, 18%) | Battery-grade LiOH monohydrate from POSCO JV (two trains) | Korean cathode/battery makers | Commissioned 2023–24 | POSCO marketing; PLS share equity-accounted |
Battery Material Exchange (BMX) | Digital auction platform for spot spodumene sales | Converters, traders | Launched 2021 | — |
Colina lithium concentrate (future) | Planned Brazilian spodumene production | Global converters | Pending FS and FID | Not yet applicable |
“—” = not publicly disclosed.
Financial Narrative
Income statement
Sources: FY22 revenue/NPAT and FY23 figures from FY23 Full Year Results release and Annual Report 2023 (FY22 EBITDA ~A$0.8bn per FY23 release commentary; not shown as exact); FY24 from FY24 Full Year Results release (underlying EBITDA A$538M; one report cites A$528M — discrepancy noted); FY25 and FY26 from FY26 Full Year Results release (FY25 restated on FY26 underlying definition).
Revenue CAGR FY22–FY26: ≈12.9% (derived). This hides an extreme cycle: revenue rose 242% in FY23, then fell 69% in FY24 and a further ~39% in FY25 before rebounding 152% in FY26.
Commentary. PLS's P&L is dominated by price. FY23 realised prices at the 2022–23 peak delivered an 82% EBITDA margin; the FY24 74% collapse in realised price cut EBITDA 84% despite 16–17% volume growth. FY25 was the trough (realised US$672/t, statutory loss A$196M after depreciation of the expanded P1000 asset base). FY26's turnaround came from a 121% higher realised price, 17% more volume and a 9% lower FOB unit cost, producing operating leverage of roughly 12x EBITDA growth on 2.5x revenue growth. Statutory NPAT was held back by higher depreciation and a return to tax-paying status. The reported FY26 NPAT fell short of the average analyst estimate (Bloomberg, 24 Aug 2026).
Half-year and quarterly granularity (FY26)
Sources: FY26 results appendix (physicals); Sep 2025, Mar 2026, Jun 2026 quarterly reports. H1 FY26: underlying EBITDA A$253M; NPAT A$33M, impacted by non-recurring mid-stream and P-PLS costs (Bell Potter via FNArena, 20 Feb 2026); H1 revenue up 47% YoY.
Balance sheet
Sources: FY23 Annual Report (NTA; cash ~A$3.3bn per results coverage); FY24 results (cash A$1,626M; some reports round to A$1.6bn); FY26 results and June 2026 quarterly (cash, liquidity, net cash).
Cash flow
Sources: FY24 earnings call (cash margin A$513M); FY26 results (cash margin, capex, cash increase incl. bond proceeds). FY24 operating FCF ≈ A$333M excluding a A$773M FY23 tax true-up (company commentary via Stockhead). Buybacks: none identified FY22–FY26.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Business Units
| Unit | Contents | Status FY26 | Revenue contribution |
|---|---|---|---|
Pilgangoora Operation (WA, Australia) | Pilgan Plant (P1000, ~1Mtpa nameplate) and Ngungaju Plant (~200ktpa); mine, ore sorting, Port Hedland logistics | Producing; Ngungaju restarted 1 Jul 2026 | ~100% |
Colina Project (Minas Gerais, Brazil) | Hard-rock lithium deposit acquired via Latin Resources | Feasibility study; exploration budget up to A$55M | 0% |
P-PLS chemical JV (Gwangyang, South Korea) | 18% equity in POSCO Pilbara Lithium Solution lithium hydroxide facility | Equity-accounted; non-recurring losses in H1 FY26 | Equity accounted (excluded from underlying EBITDA) |
Mid-Stream Demonstration Plant (Pilgangoora) | Lithium phosphate / mid-stream product demonstration, ARENA co-funded | Commissioning; first product expected Sep Qtr 2026 | 0% |
Corporate | West Perth head office, treasury, marketing | — | — |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
Total revenue (AUD Mn) | 1,254 | 769 | 1,934 |
Pilgangoora share of revenue (%) | 100 | 100 | 100 |
Spodumene concentrate sold (kt) | — | 760.1 | 891.6 |
Tantalite concentrate shipped (klb) | — | 178.1 | 239.1 |
Underlying EBITDA (AUD Mn) | 538 | 97 | 1,137 |
Underlying EBITDA margin (%) | 43 | 13 | 59 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (AUD Mn) | 1,190 | 4,064 | 1,254 | 769 | 1,934 |
EBITDA / Underlying EBITDA (AUD Mn) | — | 3,320 | 538 | 97 | 1,137 |
EBITDA margin (%) | 68 | 82 | 43 | 13 | 59 |
Statutory NPAT (AUD Mn) | 562 | 2,391 | 257 | -196 | 526 |
Underlying NPAT (AUD Mn) | — | 2,276 | 318 | — | — |
Net margin (%, derived) | 47.2 | 58.8 | 20.5 | -25.5 | 27.2 |
Dividends per share (A cents) | 0 | 25 | 0 | 0 | 5 |
Production (kt SC) | 378 | 620 | 725 | 754.6 | 879.5 |
Realised price (US$/t, as reported grade basis) | — | — | — | 672 | 1,488 |
Unit operating cost FOB (A$/t) | — | — | — | 627 | 569 |
Unit operating cost CIF (A$/t) | — | — | — | 735 | 739 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansOperating Metrics (kt) and Income Statement
| Metric | Sep Q FY26 | Dec Q FY26 | Mar Q FY26 | Jun Q FY26 |
|---|---|---|---|---|
Spodumene produced (kt) | 224.8 | 208.0 | 232.4 | 214.3 |
Spodumene shipped (kt) | 214.0 | 232.0 | 195.7 | 249.9 |
Ore mined (Mwmt) | 1.73 | 1.51 | 1.29 | 1.67 |
Total material mined (Mwmt) | 7.70 | 8.14 | 9.89 | 10.18 |
Average Li2O grade mined (%) | 1.2 | 1.3 | 1.4 | 1.4 |
Lithia recovery (%) | 78.2 | 75.8 | 75.4 | 76.8 |
Realised price (US$/t, ~SC5.2) | 742 | — | — | 2,107 |
Unit cost FOB (A$/t) | — | — | 520 | 616 |
Quarter revenue (AUD Mn) | 251 | — | — | 743 |
Closing cash (AUD Mn) | 852 | — | 1,455 | 2,290 |
Key Financials and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash & equivalents (AUD Mn) | — | 3,300 | 1,626 | 974 | 2,290 |
Total liquidity incl. undrawn facilities (AUD Mn) | — | — | — | 1,599 | 2,790 |
Net cash (AUD Mn) | — | — | — | — | 1,344 |
Total debt (AUD Mn, derived = cash − net cash) | — | — | — | — | 946 |
Net tangible assets per share (AUD) | 0.43 | 1.13 | 1.08 | — | — |
Cash Flow
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Cash margin from operations (AUD Mn) | — | — | 513 | 192 | 1,357 |
Capex (AUD Mn) | — | — | — | 569 | 328 |
Dividends determined (AUD Mn, approx.) | 0 | 750 | 0 | 0 | 161 |
Change in cash (AUD Mn) | — | — | — | — | 1,316 |
Margin Analysis (%)
| Ratio | FY26 value | Basis |
|---|---|---|
Underlying EBITDA margin | 59% | Reported |
Net margin | 27.2% | Derived |
Net debt / EBITDA | Net cash (−1.2x) | Derived: −1,344 / 1,137 |
Gross interest cost on notes | ~US$41M p.a. | Derived: 6.875% × US$600M |
EBITDA / note interest | ~18x | Derived (A$ conversion approx.) |
Capex / revenue | 17% | Derived |
Revenue by Region and Revenue by Region (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Total revenue (AUD Mn) | 1,254 | 769 | 1,934 |
Revenue from Australian-sourced production (%) | 100 | 100 | 100 |
Revenue from Brazil (AUD Mn) | 0 | 0 | 0 |
Valuation Snapshot
| Metric | Value | Source/date |
|---|---|---|
Share price (latest verified) | A$4.43 | — |
Share price 26 Aug 2026 | A$5.15 | Motley Fool |
All-time high |
| 2026 |
FY26 share price return | ~+275% | Motley Fool |
12-month return (to Jul 2026) | ~+226% | Motley Fool |
52-week range at 2 Dec 2025 | A$1.07–4.26 | ts2.tech |
Broker targets | Bear A$3.00; bull A$7.30; Bell Potter A$5.20 (hold); Morgan Stanley A$5.15 (hold); Ord Minnett A$6.00 (buy); UBS neutral | Aug–Oct 2026 |
P/E (FY26, derived) | ~27x at A$4.43 | Derived from ~16.3c EPS |
EV/EBITDA (FY26, derived) | ~11.4x | Derived: (~14.3bn − 1.34bn net cash) / 1.137bn |
Debt maturity | US$600M notes 2031 | Apr 2026 |
Metric | FY2022 | FY2023 |
Dividend per share (A cents) | 0 | 25 |
Analyst Conclusions
Guidance (FY27): production 1,030–1,100kt; FOB cost A$575–625/t; capex A$620–685M. P2000 feasibility in Dec Qtr 2026; FID thereafter, subject to study outcomes, funding and markets.
Bull case
-
Volume growth of ~21% in FY27 with Ngungaju, then potential doubling via P2000, provides leverage to a forecast deficit.
-
Net cash of A$1.34bn and A$2.79bn liquidity fund growth without dilution.
-
Low-cost, 100%-owned scale asset with improving recovery and cost-out momentum.
Bear case
-
Price volatility: shares are ~28% below peak as futures cooled; idle supply (~12%) can restart quickly.
-
P2000 capex inflation (to ~A$1.8–2.2bn) could dilute returns.
-
Concentration: one producing asset, China-dependent sales, and unproven chemicals ventures.
Catalysts (next 12 months): Sep Qtr FY27 report (late Oct 2026); Ngungaju reaching nameplate (~Oct 2026); 2026 AGM (Nov 2026); P2000 feasibility study (Dec Qtr 2026) and FID; Colina feasibility; mid-stream first product; H1 FY27 results (Feb 2027); lithium price trajectory.
Analyst verdict. PLS enters FY27 in the strongest position in its history: a record FY26 delivered A$1.9bn revenue, A$1.1bn underlying EBITDA at a 59% margin and A$526M NPAT, while the balance sheet moved from a A$974M cash position a year earlier to A$2.29bn cash and A$1.34bn net cash. The pivot from defence to growth was well executed: the company preserved Ngungaju during the trough, secured Canmax prepayment-backed offtake to restart it, and termed out its funding with a 2031 bond before committing to major capital. On fundamentals the asset is world-class, the cost base is competitive, and management has credibility after beating FY26 production guidance.
The investment debate now centres on two variables PLS cannot fully control or has yet to quantify. First, lithium price durability: the share price has already given back roughly a quarter of its peak as futures softened, demonstrating that PLS remains the ASX's highest-beta lithium vehicle. Second, P2000 capital intensity: estimates have risen from A$1.2bn to as much as A$2.2bn, and the December Quarter feasibility study will determine whether the expansion earns acceptable returns at mid-cycle prices. Diversification into Brazil and chemicals adds optionality but contributes nothing to earnings yet, and P-PLS has been a drag.
At around 11x derived FY26 EV/EBITDA, the market is pricing a sustained upcycle. We view PLS as a high-quality, well-financed operator whose equity is fairly valued on spot-like assumptions — consistent with the prevailing hold-weighted broker consensus. Investors should treat the P2000 FID, FY27 cost delivery against A$575–625/t guidance, and the SC6 price as the three key monitorables; a disciplined FID at sub-A$2bn capex with a sustained price above US$1,500/t SC6 would support upside toward bull targets, whereas price weakness or further capex creep would expose the downside.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title | Tenure | Background |
|---|---|---|---|
Dale Henderson | Managing Director & CEO | CEO since 1 Aug 2022 | Previously Chief Operating Officer of Pilbara Minerals (from 2016–17); engineering/operations background |
Alex Willcocks | Chief Financial Officer | From 25 May 2026 | Ex-CFO Wesfarmers Chemicals, Energy & Fertilisers; prior Kmart CFO; governance roles at Covalent Lithium (WesCEF–SQM JV); Master's in chemistry (Cambridge); CPA Australia, CIMA, GAICD |
Flavio Garofalo | Senior finance leader (former Interim CFO, mid-2025 to May 2026) | — | Led finance function reshaping and capital management |
Chief Operating Officer | — | ~1.6 years (Simply Wall St, Mar 2026) | — |
Chief Development Officer | — | ~3.2 years | — |
Chief People & Sustainability Officer | — | ~3.1 years | — |
Danielle Webber | Company Secretary | — | — |
Board of Directors
| Name | Role | Since | Notes |
|---|---|---|---|
Kathleen Conlon | Independent Non-Executive Chair | Chair from 1 Jan 2024 (director earlier) | Received share rights approved at 2025 AGM; FY25 fees ~A$425k |
Dale Henderson | Managing Director & CEO | Board from 1 Aug 2022 | Executive director |
Robert Nicholson | Non-Executive Director | 1 Jan 2026 | Energy, infrastructure and industrial board experience |
Independent NED (~9-year tenure) | NED | ~2017 | — |
Independent NED (~8-year tenure) | NED | ~2018 | — |
Directors' Remuneration
| Person | Total remuneration | Basis |
|---|---|---|
Dale Henderson (CEO) | ~A$5.09M | FY25 total remuneration (Simply Wall St) |
Flavio Garofalo (Interim CFO) | ~A$0.77M | Partial-year FY25 |
Chair | ~A$0.425M | FY25 fees |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Key asset(s) | Relative positioning |
|---|---|---|---|
Mineral Resources (ASX: MIN) | Hard-rock spodumene, WA | Wodgina, Mt Marion | Larger diversified miner; more geared |
Tianqi Lithium / IGO (TLEA) & Albemarle | Hard-rock spodumene | Greenbushes (WA) — highest-grade, lowest-cost | Cost leader ahead of PLS |
Albemarle | Integrated lithium chemicals | Greenbushes stake, Wodgina stake, Chile brine | Global #1–2 chemicals |
SQM | Brine lithium chemicals | Atacama (Chile); Mt Holland (WA) with Wesfarmers | Low-cost brine |
Ganfeng Lithium | Integrated, also a PLS customer | Global portfolio | Customer-competitor |
Rio Tinto (incl. ex-Arcadium Lithium) | Brine, hard-rock, chemicals | Argentina, Mt Cattlin, Canada | Deep-pocketed entrant |
Liontown Resources | Hard-rock spodumene, WA | Kathleen Valley | Smaller, higher-cost ramp-up |
Sigma Lithium | Hard-rock spodumene, Brazil | Grota do Cirilo (Minas Gerais) | Direct Brazil comparator to Colina |
Core Lithium | Spodumene, NT | Finniss (care & maintenance) | Marginal producer |
Zimbabwe/African producers (Sinomine, Huayou, Zhejiang-backed) | Hard-rock spodumene/petalite | Bikita, Arcadia | Low-cost Chinese-integrated supply |



